The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...

Articles were identified from EMBASE and MEDLINE using the medication name with the following search criteria: atrial fibrillation, clinical trials, pharmacoeconomic, humans, and English language.

But ever since her atrial fibrillation diagnosis, she’s been on blood thinners. And that’s been a problem. “I couldn’t tell you how many bruises I had. I would barely get tapped and I ...

Proactively managing atrial fibrillation is crucial for patients and healthcare providers, often necessitating the use of drugs due to the condition's propensity for severe consequences ...

A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...

Atrial fibrillation (AFib) is the most common form of irregular heartbeat (arrhythmia). People with AFib have many treatment options, including medications and medical procedures. However ...

Discover how abelacimab reduces bleeding risks in AFib patients by effectively lowering free factor XI levels.

A study of Boston Scientific’s Farapulse pulsed field ablation system met safety and efficacy objectives in people with persistent atrial fibrillation (AFib), an irregular heart rhythm that lasts more ...

Doylestown Health is broadening its treatment options for atrial fibrillation patients with a revolutionary system that ...

(MENAFN- GlobeNewsWire - Nasdaq) The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD 27 billion in 2025 to USD 62.64 billion ...